Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis.

  title={Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis.},
  author={D. Bates and P. R. Fawcett and D. Shaw and D. Weightman},
  journal={British Medical Journal},
  pages={1390 - 1391}
  • D. Bates, P. R. Fawcett, +1 author D. Weightman
  • Published 1978
  • Medicine
  • British Medical Journal
  • One hundred and sixteen patients with acute remitting multiple sclerosis (MS) took part in a double-blind controlled trial of treatment with polyunsaturated fatty acids and were randomly allocated to one of four groups. Two groups received linoleic acid, one alone as a spread and one with gamma-linolenic acid in capsules (Naudicelle); and two control groups received oleic acid, one as a spread and one in capsules. Rates of clinical deterioration and frequencies of attacks were not significantly… CONTINUE READING
    110 Citations
    A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis.
    • 162
    • PDF
    Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis.
    • 59
    • Highly Influenced
    • PDF
    ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial.
    • 97
    • PDF
    Supplementation of polyunsaturated fatty acids in multiple sclerosis
    • 8
    Linoleic acid and multiple sclerosis
    • 96
    A study on essential fatty acids and multiple sclerosis.
    • 4
    [Diet and multiple sclerosis].
    • 1